Identification of the abnormalities in astrocytic functions as potential drug targets for neurodegenerative disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 27, 2024 Category: Drugs & Pharmacology Authors: Valtteri Syv änenJari KoistinahoŠárka Lehtonena A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finlandb Neuroscience Center, Helsinki Institute of Life Science, and Drug Research Program, Division of Pharmacolog Source Type: research
Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities
Volume 19, Issue 4, April 2024, Page 493-506 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 26, 2024 Category: Drugs & Pharmacology Authors: Cornelia H RinderknechtMiaoran NingConnie WuMark S WilsonChristian Gampea Translational Immunology, gRED, Genentech, South San Francisco, CA, USAb Drug Metabolism and Pharmacokinetics, gRED, Genentech, South San Francisco, CA, USAc Development Sciences Sa Source Type: research
Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 26, 2024 Category: Drugs & Pharmacology Authors: Cornelia H RinderknechtMiaoran NingConnie WuMark S WilsonChristian Gampea Translational Immunology, gRED, Genentech, South San Francisco, CA, USAb Drug Metabolism and Pharmacokinetics, gRED, Genentech, South San Francisco, CA, USAc Development Sciences Sa Source Type: research
In silico drug design strategies for discovering novel tuberculosis therapeutics
Volume 19, Issue 4, April 2024, Page 471-491 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 20, 2024 Category: Drugs & Pharmacology Authors: Christian S. Carnero CanalesAline Renata PavanJean Leandro dos SantosFernando Rog ério Pavana School of Pharmaceutical Science, São Paulo State University (UNESP), Araraquara, Brazilb School of Pharmacy, biochemistry and biotechnology, Santa Maria Catho Source Type: research
In silico drug design strategies for discovering novel tuberculosis therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 20, 2024 Category: Drugs & Pharmacology Authors: Christian S. Carnero CanalesAline Renata PavanJean Leandro dos SantosFernando Rog ério Pavana School of Pharmaceutical Science, São Paulo State University (UNESP), Araraquara, Brazilb School of Pharmacy, biochemistry and biotechnology, Santa Maria Catho Source Type: research
The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma
Volume 19, Issue 4, April 2024, Page 377-391 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 19, 2024 Category: Drugs & Pharmacology Authors: Irene StrasslKlaus Podara Division of Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Department of Internal Medicine I, Ordensklinikum Linz Hospital, Linz, Austriab Medical Faculty, Johannes Kepler University Linz, Linz, A Source Type: research
The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 19, 2024 Category: Drugs & Pharmacology Authors: Irene StrasslKlaus Podara Division of Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Department of Internal Medicine I, Ordensklinikum Linz Hospital, Linz, Austriab Medical Faculty, Johannes Kepler University Linz, Linz, A Source Type: research
What value do zebrafish have to anticancer drug discovery?
Volume 19, Issue 4, April 2024, Page 369-375 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 8, 2024 Category: Drugs & Pharmacology Authors: Boyuan XiaoEsther Landesman-BollagHui Fenga Department of Pharmacology, Physiology & Biophysics, Cancer Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USAb Department of Medicine, Section of Hematology and Medic Source Type: research
What value do zebrafish have to anticancer drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 8, 2024 Category: Drugs & Pharmacology Authors: Boyuan XiaoEsther Landesman-BollagHui Fenga Department of Pharmacology, Physiology & Biophysics, Cancer Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USAb Department of Medicine, Section of Hematology and Medic Source Type: research
Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery
Volume 19, Issue 4, April 2024, Page 415-431 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 7, 2024 Category: Drugs & Pharmacology Authors: Ella Czarina MorishitaShingo NakamuraVeritas In Silico Inc, Tokyo, Japan Source Type: research
Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 7, 2024 Category: Drugs & Pharmacology Authors: Ella Czarina MorishitaShingo NakamuraVeritas In Silico Inc, Tokyo, Japan Source Type: research
Chemoinformatic approaches for navigating large chemical spaces
Volume 19, Issue 4, April 2024, Page 403-414 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 5, 2024 Category: Drugs & Pharmacology Authors: Martin VogtDepartment of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universit ät, Bonn, Germany Source Type: research
Chemoinformatic approaches for navigating large chemical spaces
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - February 1, 2024 Category: Drugs & Pharmacology Authors: Martin VogtDepartment of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universit ät, Bonn, Germany Source Type: research
Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy
Volume 19, Issue 4, April 2024, Page 393-402 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - January 28, 2024 Category: Drugs & Pharmacology Authors: Violaine Plant é-BordeneuveValentine Perraina Department of Neurology, Henri Mondor University Hospital, AP-HP, Créteil, Franceb Mondor Biomedical Research Institute – IMRB, INSERM, U955 Team 10 “Biology of the Neuromuscular System”, Créteil, Fra Source Type: research
